Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Disseminated Intravascular Coagulation (DIC) Market From 2025 To 2029?
Over the past few years, the disseminated intravascular coagulation (dic) market has expanded steadily. It is projected to increase from $0.46 billion in 2024 to $0.49 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.0%. The growth during the historical period is driven by factors such as the increasing occurrence of sepsis, rise in trauma incidents, growth in cancer cases, increased healthcare expenditure, heightened awareness among healthcare practitioners, and an uptick in the adoption of targeted therapies.
In the upcoming years, the market size for disseminated intravascular coagulation (dic) is predicted to experience steady growth, ballooning to a value of$0.59 billion by 2029 with a compound annual growth rate (CAGR) of 4.9%. Factors contributing to this predicted growth in the forecast period include the rising uptake on targeted therapies, an increasing emphasis on early detection of diseases, surge in healthcare infrastructure investments, growth in clinical research concerning coagulopathy treatments, and increased awareness about rare blood disorders. The forecast period is expected to see trending enhancements like better diagnostic tests, popularity of innovative anticoagulant therapies, tailored medicine strategies, use of AI in diagnostics, sophisticated patient monitoring technologies, and the progression of targeted treatments.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21172&type=smp
What External and Internal Drivers Are Contributing to the Growth of theDisseminated Intravascular Coagulation (DIC) Market?
The rise in cancer incidence is poised to propel the expansion of the disseminated intravascular coagulation (DIC) market. Cancer, a disease marked by uncontrolled cell growth and spread, potentially damaging normal tissues, is on the rise due to an aging population, lifestyle shifts, environmental factors, infections, and genetic predisposition. Cancer can precipitate disseminated intravascular coagulation (DIC) by excessively activating the coagulation sequence with tumor-produced procoagulant substances, leading to widespread clotting and bleeding. As per the National Cancer Institute, an American government agency, there were nearly 20 million new cancer cases and 9.7 million cancer-related deaths globally in 2022. Forecasts indicate that these numbers could grow to 29.9 million new cases and 15.3 million deaths per year by 2040. Subsequently, the growing incidence of cancer is fueling the expansion of the disseminated intravascular coagulation (DIC) market.
What Segment Types Define the Disseminated Intravascular Coagulation (DIC) Market Structure?
The disseminated intravascular coagulation (dic)market covered in this report is segmented –
1) By Treatment: Medicines; Transfusions; Surgery; Other Treatments
2) By Diagnosis: Complete Blood Count With Blood Smear Exam; Partial Thromboplastin Time (PTT); Fibrinogen Blood Test; D-dimer; Other Diagnoses
3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
Subsegments:
1) By Medicines: Anticoagulants; Antiplatelet Drugs; Fibrinolytics; Procoagulants; Antithrombin Therapy
2) By Transfusions: Platelet Transfusion; Fresh Frozen Plasma (FFP); Cryoprecipitate Transfusion; Red Blood Cell Transfusion
3) By Surgery: Surgical Removal Of Thrombus; Organ Surgery
4) By Other Treatments: Plasma Exchange; Supportive Care; Steroid Therapy
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21172&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Disseminated Intravascular Coagulation (DIC) Market?
North America was the largest region in the disseminated intravascular coagulation (DIC) market in 2024. The regions covered in the disseminated intravascular coagulation (DIC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Long-Term Trends Are Transforming the Competitive Landscape of the Disseminated Intravascular Coagulation (DIC) Market?
Leading firms in the disseminated intravascular coagulation (DIC) market are evolving their focus towards the improvement of coagulation diagnostic technologies. This includes the development of next-generation blood clotting tests to bolster the precision, swiftness, and simplicity of DIC diagnosis, promoting prompt treatment actions and enhanced patient results. Next-generation blood clotting tests suggest the development of cutting-edge diagnostic means and approaches to gauge blood coagulation more precisely and comprehensively than conventional tests. For example, in June 2022, LumiraDx Limited, a healthcare company based in the UK, enriched its cardiovascular testing suite with CE Mark approvals for its NT-proBNP and updated D-Dimer tests, thus augmenting the LumiraDx Platform’s capacity to assist medical practitioners in diagnosing heart failure and excluding venous thromboembolism at the point of care. These advancements are aimed at enhancing the early identification and management of cardiovascular and thrombotic conditions, such as disseminated intravascular coagulation (DIC).
View the full report here:
What Is the Definition of the Disseminated Intravascular Coagulation (DIC) Market?
Disseminated intravascular coagulation (DIC) is a complex, life-threatening condition characterized by excessive blood clotting followed by severe bleeding due to the depletion of clotting factors and platelets. It is triggered by underlying conditions such as sepsis, trauma, malignancies, and obstetric complications.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21172
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model